Petros Pharmaceuticals, Inc. Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee
Petros Pharmaceuticals, Inc. (PTPI) had Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee of 29.00% as of 2023-07-13, per its 10-K filed 2024-04-01.
Discontinued › Notes
us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee · last filed 2024-04-01
- 2023-07-13: Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee 29.00%.
| Period end | Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee |
|---|---|
| 2023-07-13 | 29.00% 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |